##common.pageHeaderLogo.altText##

Viewpoint

Vol. 154 No. 8 (2024)

Should asleep deep brain stimulation in Parkinson’s disease be preferred over the awake approach? – Pros

  • Gerd Tinkhauser
  • Claudio Pollo
  • Ines Debove
  • Andreas Nowacki
  • Paul Krack
Cite this as:
Swiss Med Wkly. 2024;154:3823
Published
09.08.2024

Summary

No abstract available.

References

  1. Schulder M, Mishra A, Mammis A, Horn A, Boutet A, Blomstedt P, et al. Advances in Technical Aspects of Deep Brain Stimulation Surgery. Stereotact Funct Neurosurg. 2023;101(2):112–34. 10.1159/000529040
  2. Mulroy E, Robertson N, Macdonald L, Bok A, Simpson M. Patients’ Perioperative Experience of Awake Deep-Brain Stimulation for Parkinson Disease. World Neurosurg. 2017 Sep;105:526–8. 10.1016/j.wneu.2017.05.132
  3. LaHue SC, Ostrem JL, Galifianakis NB, San Luciano M, Ziman N, Wang S, et al. Parkinson’s disease patient preference and experience with various methods of DBS lead placement. Parkinsonism Relat Disord. 2017 Aug;41:25–30. 10.1016/j.parkreldis.2017.04.010
  4. Krack P, Volkmann J, Tinkhauser G, Deuschl G. Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy. Mov Disord. 2019 Dec;34(12):1795–810. 10.1002/mds.27860
  5. Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: methodologic aspects and clinical criteria. Neurology. 2000;55(12 Suppl 6):S40–4.
  6. Gadot R, Vanegas Arroyave N, Dang H, Anand A, Najera RA, Taneff LY, et al. Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2022 Aug;138(4):1016–27. 10.3171/2022.6.JNS212904
  7. Nguyen TA, Nowacki A, Debove I, Petermann K, Tinkhauser G, Wiest R, et al. Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: proof of concept. Brain Stimul. 2019;12(5):1127–34. 10.1016/j.brs.2019.05.001
  8. Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, et al. Bilateral subthalamic stimulation for Parkinson’s disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg. 2000 Apr;92(4):615–25. 10.3171/jns.2000.92.4.0615
  9. Hariz MI, Bergenheim AT. A comparative study on ventriculographic and computerized tomography-guided determinations of brain targets in functional stereotaxis. J Neurosurg. 1990 Oct;73(4):565–71. 10.3171/jns.1990.73.4.0565
  10. Isaacs BR, Keuken MC, Alkemade A, Temel Y, Bazin PL, Forstmann BU. Methodological Considerations for Neuroimaging in Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Patients. J Clin Med. 2020 Sep;9(10):3124. 10.3390/jcm9103124
  11. Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecordings of the subthalamic nucleus in Parkinson’s disease. Mov Disord. 2002;17(S3 Suppl 3):S145–9. 10.1002/mds.10156
  12. Pollak P, Krack P, Fraix V, Mendes A, Moro E, Chabardes S, et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson’s disease. Mov Disord. 2002;17(S3 Suppl 3):S155–61. 10.1002/mds.10158
  13. Tinkhauser G. The present and future role of clinical neurophysiology for Deep Brain Stimulation. Clin Neurophysiol. 2022 Aug;140:161–2. 10.1016/j.clinph.2022.05.012
  14. Liu Z, He S, Li L. General Anesthesia versus Local Anesthesia for Deep Brain Stimulation in Parkinson’s Disease: A Meta-Analysis. Stereotact Funct Neurosurg. 2019;97(5-6):381–90. 10.1159/000505079
  15. Krack P. Subthalamic stimulation for Parkinson’s disease: a new benchmark. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):356–7. 10.1136/jnnp.2010.222497
  16. Foltynie T, Zrinzo L, Martinez-Torres I, Tripoliti E, Petersen E, Holl E, et al. MRI-guided STN DBS in Parkinson’s disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):358–63. 10.1136/jnnp.2010.205542
  17. Holewijn RA, Verbaan D, van den Munckhof PM, Bot M, Geurtsen GJ, Dijk JM, et al. General Anesthesia vs Local Anesthesia in Microelectrode Recording-Guided Deep-Brain Stimulation for Parkinson Disease: The GALAXY Randomized Clinical Trial. JAMA Neurol. 2021 Oct;78(10):1212–9. 10.1001/jamaneurol.2021.2979
  18. Erdman HB, Kornilov E, Kahana E, Zarchi O, Reiner J, Socher A, et al. Asleep DBS under ketamine sedation: proof of concept. Neurobiol Dis. 2022 Aug;170:105747. 10.1016/j.nbd.2022.105747
  19. Nikolov P, Heil V, Hartmann CJ, et al. Motor Evoked Potentials Improve Targeting in Deep Brain Stimulation Surgery. Neuromodulation : journal of the International Neuromodulation Society 2022;25(6):888-894. 10.1111/ner.13386
  20. Engelhardt J, Caire F, Damon-Perrière N, Guehl D, Branchard O, Auzou N, et al. A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease. Stereotact Funct Neurosurg. 2021;99(3):230–40. 10.1159/000511424
  21. Jacob RL, Geddes J, McCartney S, Burchiel KJ. Cost analysis of awake versus asleep deep brain stimulation: a single academic health center experience. J Neurosurg. 2016 May;124(5):1517–23. 10.3171/2015.5.JNS15433
  22. Kühn AA, Volkmann J. Innovations in deep brain stimulation methodology. Mov Disord. 2017 Jan;32(1):11–9. 10.1002/mds.26703
  23. Neumann WJ, Gilron R, Little S, Tinkhauser G. Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation. Mov Disord. 2023 Jun;38(6):937–48. 10.1002/mds.29415
  24. Segura-Amil A, Nowacki A, Debove I, Petermann K, Tinkhauser G, Krack P, et al. Programming of subthalamic nucleus deep brain stimulation with hyperdirect pathway and corticospinal tract-guided parameter suggestions. Hum Brain Mapp. 2023 Aug;44(12):4439–51. 10.1002/hbm.26390
  25. Pollo C, Kaelin-Lang A, Oertel MF, Stieglitz L, Taub E, Fuhr P, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014 Jul;137(Pt 7):2015–26. 10.1093/brain/awu102
  26. Averna A, Debove I, Nowacki A, Peterman K, Duchet B, Sousa M, et al. Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation. Mov Disord. 2023 May;38(5):818–30. 10.1002/mds.29381
  27. Debove I, Petermann K, Nowacki A, Nguyen TK, Tinkhauser G, Michelis JP, et al. Deep Brain Stimulation: When to Test Directional? Mov Disord Clin Pract. 2023 Feb;10(3):434–9. 10.1002/mdc3.13667
  28. Horn A, Fox MD. Opportunities of connectomic neuromodulation. Neuroimage. 2020 Nov;221:117180. 10.1016/j.neuroimage.2020.117180
  29. Ho AL, Ali R, Connolly ID, Henderson JM, Dhall R, Stein SC, et al. Awake versus asleep deep brain stimulation for Parkinson’s disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):687–91. 10.1136/jnnp-2016-314500
  30. Sheshadri V, Rowland NC, Mehta J, Englesakis M, Manninen P, Venkatraghavan L. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques 2017;44(6):697-704. 10.1017/cjn.2017.224
  31. Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, et al. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018 Mar;130(1):109–20. 10.3171/2017.8.JNS17883
  32. Lachenmayer ML, Mürset M, Antih N, Debove I, Muellner J, Bompart M, et al. Subthalamic and pallidal deep brain stimulation for Parkinson’s disease-meta-analysis of outcomes. NPJ Parkinsons Dis. 2021 Sep;7(1):77. 10.1038/s41531-021-00223-5